Literature DB >> 11810220

Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro.

Stefan Ruf1, Michael Piper, Klaus-Dieter Schlüter.   

Abstract

The study addressed the question of why in adult ventricular rat cardiomyocytes ERK activation is required for the hypertrophic stimulation caused by angiotensin II but not in the case of alpha-adrenoceptor stimulation. We therefore compared in the same culture system the intracellular signaling steps that are involved in inducing the hypertrophic growth evoked by stimulating either of these two receptors. alpha-Adrenoceptor stimulation strongly increased protein synthesis ([14C]phenylalanine incorporation) up to 53% in a PKC- and p70s6k-dependent, but ERK-independent way. In contrast, angiotensin II increased protein synthesis less efficiently (by 23%), in a PKC-, p70s6k-, but ERK-dependent way. The kinetics of activation for ERK were different for the two hypertrophic stimuli: alpha-adrenoceptor stimulation caused a rapid and transient activation, but angiotensin II caused a rapid and sustained activation. In contrast to alpha-adrenoceptor stimulation, angiotensin II activated calcium-independent PKC isoforms but not calcium-dependent PKC isoforms. In conclusion, ERK activation by angiotensin II is sustained and leads to an increase in protein synthesis on adult ventricular cardiomyocytes, but ERK activation by alpha-adrenoceptor stimulation is transient and not involved in hypertrophic growth responsiveness. The ERK-dependent pathway seems to be less efficient than ERK-independent pathways. The difference in the hypertrophic responsiveness of cardiomyocytes exposed to either of the two stimuli may be explained by the activation of different PKC isoform types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810220     DOI: 10.1007/s004240100710

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  8 in total

1.  Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.

Authors:  Nynke E Hahn; René J P Musters; Jan M Fritz; Patrick J Pagano; Alexander B A Vonk; Walter J Paulus; Albert C van Rossum; Christof Meischl; Hans W M Niessen; Paul A J Krijnen
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

2.  Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.

Authors:  Neil A Roberts; Robert S Haworth; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat.

Authors:  D Schröder; J Heger; H M Piper; G Euler
Journal:  J Mol Med (Berl)       Date:  2006-08-19       Impact factor: 4.599

4.  Stimulatory action of protein kinase C(epsilon) isoform on the slow component of delayed rectifier K+ current in guinea-pig atrial myocytes.

Authors:  H Toda; W-G Ding; Y Yasuda; F Toyoda; M Ito; H Matsuura; M Horie
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

5.  Post-conditioning restores pre-ischaemic receptor coupling in rat isolated hearts.

Authors:  Rolf Schreckenberg; Thorsten Maier; Klaus-Dieter Schlüter
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 6.  Calcium signaling phenomena in heart diseases: a perspective.

Authors:  Sajal Chakraborti; Sudip Das; Pulak Kar; Biswarup Ghosh; Krishna Samanta; Saurav Kolley; Samarendranath Ghosh; Soumitra Roy; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.842

7.  The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II.

Authors:  Huixin Guo; Baoxin Liu; Lei Hou; Erlinda The; Gang Li; Dongzhi Wang; Qiqiang Jie; Wenliang Che; Yidong Wei
Journal:  Int J Mol Med       Date:  2015-03-02       Impact factor: 4.101

8.  Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes.

Authors:  Gerhild Euler; Fabian Locquet; Joanna Kociszewska; Yvonne Osygus; Jacqueline Heger; Rolf Schreckenberg; Klaus-Dieter Schlüter; Éva Kenyeres; Tamara Szabados; Péter Bencsik; Péter Ferdinandy; Rainer Schulz
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-05       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.